Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer.

Zhang R, Qi F, Zhao F, Li G, Shao S, Zhang X, Yuan L, Feng Y. · 2019

Read Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer. by Zhang R, Qi F, Zhao F, Li G, Shao S, Zhang X, Yuan L, Feng Y. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6426970.txt.

Introduction

Zhang and co-authors trace how cancer-associated fibroblasts and tumor macrophages cooperate to weaken natural killer cells in colorectal cancer. Both cell types crowd the tissue around tumors and help cancers grow, partly by damping immune attack. The detailed handoffs between them were only partly understood.

Fibroblasts raised VCAM-1 on cancer cells, which helped monocytes stick and gather, and released IL-8 to draw more monocytes in. Those monocytes matured into M2-type macrophages, which joined the fibroblasts in suppressing killer cell activity. Removing macrophages or lowering VCAM-1 partly cancelled the fibroblasts' tumor support in animals. The chain of signals offers several points where treatment might break the partnership.

Catalog record

CREATORZhang R, Qi F, Zhao F, Li G, Shao S, Zhang X, Yuan L, Feng Y.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE44 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6426970

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Cancer-associated fibroblasts enhance tumor-associated macrophages enrichment and suppress NK cells function in colorectal cancer By Rongsheng Zhang, Fan Qi, Fei Zhao, Geng Li, Shengli Shao, Xiaochao Zhang, Lifei Yuan, Yongdong Feng Published in: Cell Death & Disease DOI: 10.1038/s41419-019-1435-2 ABSTRACT Cancer-associated fibroblasts (CAFs) and tumor-associated macrophages (TAMs) are important components of the tumor microenvironment, which have been reported to localize in colorectal carcinomas where they promote tumor progression. One of the crucial effects they exerted is immune-suppression, which was reported recently, however, the overall mechanism has not been fully addressed. In this study, it was shown that TAMs were enriched in colorectal cancer, and their infiltration was associated with VCAM-1 expression. Human colorectal cancer-derived CAFs can promote the adhesion of monocytes by up-regulating VCAM-1 expression in colorectal cancer cells. Furthermore, CAFs can attract monocytes by secreting IL-8 rather than SDF-1 and subsequently promote M2 polarization of macrophages, which synergize with CAFs in suppressing the functioning of natural killer (NK) cells. It was also found that CAFs promoted M2 macrophages recruitment in tumor tissue in vivo, and after VCAM-1 knocking-down in tumor cells or depletion of macrophages, the pro-tumor effect of CAFs was partly abolished, but no change was observed in NK cells infiltration. Collectively, the findings in this work show that TAMs and CAFs function synergistically in the tumor microenvironment and have the capacity to regulate NK cells in colorectal cancer and this presents a novel mechanism. INTRODUCTION Tumor cells are surrounded by stroma, which consists of various inflammatory cells, endothelial cell, and fibroblasts. Evolving crosstalk between different cells results in the progression of tumor, however the underlying mechanism is complex and remains obscure. Cancer-associated fibroblasts (CAFs) are abundant stromal cells in the tumor microenvironment, they secrete cytokines such as HGF, IL-6, and SDF-1, which have a variety of effects on cancer cells and stroma1–8, including angiogenesis, tumor growth, migration, and are an alternative for extracellular matrix. Tumor-associated macrophages (TAMs), which are also dominant cell type in the tumor milieu, are estimated to account for up to 50% of cancer tissue mass9. There are two types of polarized macrophages: classically activated (M1) macrophages which activate immune response10,11 and alternatively activated (M2) macrophages which promote tumor progression12–15. The properties of TAMs are similar to those of M2 polarized macrophages. Natural killer (NK) cells play an important role in the innate immune system, they can kill tumor cells without the necessity of prior sensitization16, NK-92 is a continuously expanding cytotoxic NK cells line which is under development for clinical application17,18. NK cells have advantages over T cell in their use for CAR-targeted immunotherapy, because they do not have MHC restriction, thus are not responsible for graft-versus-host disease (GVHD). Despite their therapeutic potential, NK cells therapies have limited success due to the suppression of tumor microenvironment. It has been reported that NK cells are no longer lyse tumor cells and express lower levels of activating receptor NKG2D after adoptive transfer19, which indicates that cells other than tumor cell suppress the function of NK cells in tumor microenvironment. Recently, it was reported that the immune-suppression role was played by CAFs or TAMs, but the overall mechanism remains obscure. In the present study, colorectal cancer-derived CAFs (CC-CAFs) were isolated from human colorectal cancer (CRC) tissue, after which their effect on adhesion, recruitment of monocytes, and polarization of macrophages were investigated. NK cells-suppression effects of TAMs and CAFs were evaluated, in vivo experiments were used to further confirm the overall effects. It was found that CAFs attracted monocytes by secretion of IL-8 and promoted adhesion between monocytes and CRC cells by secretion of IL-6. Moreover, CAFs promoted M2 polarization of macrophages, which synergized with CAFs suppression function rather than recruitment of NK cells. The results in this study confirmed that TAMs and CAFs were synergetic and had the capacity to regulate NK cells in CRC and presented a novel mechanism for the effect. RESULTS VCAM-1 overexpression is associated with TAMs enrichment As shown in Fig. 1a, high VCAM-1 expression and CD206 (+) macrophages infiltration were observed in cancer tissues compared with normal tissue in CRC, these findings were further analyzed by flow cytometry. To exclude vascular endothelium and other hemocytes which usually express VCAM-1, the epithelial cells were gated as CD45− epCAM+ subpopulation. The results showed that the expression of VCAM-1 in CRC cells was higher compared with normal epithelium (Fig. 1c). This assay confirmed the enrichment of macrophage (CD11b+CD68+) in cancer tissue (Fig. 1d). Moreover, higher infiltration of CD163+CD206+ TAM was observed (Fig. 1e). To explore whether VCAM-1 expression was associated with TAM infiltration, TCGA colon adenocarcinoma was used to examine the correlation between CD163 and VCAM-1 via the R2: Genomics Analysis and Visualization Platform (http://r2.amc.nl). As shown in Fig. 1f, CD163 expression was positively associated with VCAM-1 expression in colon adenocarcinoma, and the IHC analysis and quantification in clinical specimen also showed the positive correlation between CD206 and VCAM-1 expression (Fig. 1g), which showed TAM infiltration in VCAM-1 overexpression CRC tissue was higher compared with VCAM-1 low expression CRC tissue or normal tissue. These results point to a possible association between VCAM-1 expression in cancer tissue and M2 macrophages infiltration.Fig. 1VCAM-1 overexpression is associated with TAMs enrichment.a Immunofluorescence of CD206 (green) and VCAM-1 (red) expression of CRC tissue and para-CRC (para-colorectal cancer) normal tissue (magnification, ×400, scale bar: 50 μm), nuclei were visualized by DAPI. b HE stain of para-CRC normal tissue and CRC tissue. (magnification, ×200, scale bar: 100 μm). c FACS analysis of VCAM-1 expression in the epithelium or CRC cells which gated as CD45- epCAM+. d FACS analysis and quantification of CD11b (+) CD68 (+) macrophages in human CRC tissue and para-CRC normal tissue. e FACS analysis and quantification of CD163 (+) CD206 (+) cells in normal tissue macrophages (NTMs) and TAMs. f VCAM-1 expression was positively associated with CD163 in clinical colorectal cancer specimens (R = 0.65, P < 0.001). Gene correlation analysis was based on the TCGA colorectal cancer dataset and was analyzed via the R2: Genomics Analysis and Visualization Platform. g IHC analysis and quantification of CD206 expression in para-CRC normal tissue, VCAM-1 low expression CRC tissue, and VCAM-1 high expression CRC tissue (scale bar: 100 μm). Error bars represent mean ± s.d.; **P < 0.01; ***P < 0.001; n.s. not significant; by unpaired two-sided Student’s t-test (b, c, e) CC-CAFs promote adhesion between monocytes and CRC cells through VCAM-1/IL-6 As shown in Fig. 2a, CAFs and normal fibroblasts (NFs) were isolated from human CRC tissues and para-cancer normal tissues. Western blot and immunofluorescence were used to identify the phenotype of CAFs as higher expression of α-SMA, FSP, and vimentin compared with NFs. Effects of CAFs on CRC cells line SW48 were investigated using CAFs-CM culture system. Figure 2b shows that VCAM-1 was up-regulated after cultured in CAFs-CM based on immunofluorescence, which was further confirmed by flow cytometry (Fig. 2e). To identify the cytokine which promoted enhanced VCAM-1 expression, CAFs and NFs were cultured in serum-starved F12 for 24 h, the level of IL-6 and IL-8 were determined by ELISA. As shown in Fig. 2d, the level of IL6 and IL8 was significantly higher in CAFs-derived condition medium (CM) compared with that presented in NFs-derived CM, but SDF-1

Read the complete text